Sunday, April 25, 2021

A pharmacist-driven Food and Drug Administration incident surveillance and response program for compounded drugs Ashlee N Janusziewicz 1, Shannon N Glueck 1, Sophia Y Park 1, Dien N Nguyen 1, Susan C Rimmel 1, Laurelle A Cascio 1, Gina Y Doh 1, Garrette F Martin-Yeboah 1

https://pubmed.ncbi.nlm.nih.gov/33889929/ 

No comments: